4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-053503
Chairman and CEO bought 13,200 shares at an average $1.54 ($20,312)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-08-24 | Purchase | +1,500 | $1.48 | $2,220 | 10,846,164 | D |
| Niihara Yutaka Chairman and CEO | 2021-08-25 | Purchase | +5,350 | $1.53 | $8,186 | 10,851,514 | D |
| Niihara Yutaka Chairman and CEO | 2021-08-26 | Purchase | +6,350 | $1.56 | $9,906 | 10,857,864 | D |
| Open-market purchases · 13,200 sh · avg $1.54 · $20,312 | |||||||
Loading xslF345X03/doc4.xml…